Analgesic Efficacy of Different Volumes in Erector Spinae Plane Block in Single Level Lumbar Spine Fixation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-01

Study Completion Date

2023-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The analgesic efficacy of different volumes in ESPB patients undergoing single-level lumbar spine fixation

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Erector Spinae Plane Block in Spine Surgeries for Postoperative Pain

NCT06970704

Spine Fusion Spine Metastases Postoperative Pain

COMPLETED NA

Effectiveness of Bilateral Ultrasound-Guided Erector Spinae Plane Block

NCT04110210

Erector Spinae Plane Block

COMPLETED EARLY_PHASE1

Erector Spinae Plane Block in Spine Surgeries

NCT05247021

Lumbar Disc Disease

UNKNOWN PHASE4

Analgesic Efficacy of the Erector Spinae Plane Block Using Bupivacaine Versus Bupivacaine/Magnesium Sulphate in Patients Undergoing Lumbar Spine Surgery

NCT04433624

Postoperative Pain

UNKNOWN NA

Comparative Study Between Caudal Epidural Block and Bilateral Erector Spinae Plane Block in Lumbosacral Spine Surgeries.

NCT05729308

Postoperative Pain, Acute

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The erector spinae plane block (ESPB) its an interfacial plane block for an effective treatment for thoracic neuropathic pain. Currently, compared to the use of opioids, the ESPB has fewer side effects and is safe for patients of all ages having abdominal and thoracic operations .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector 10

Received 10ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Group Type EXPERIMENTAL

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%

Erector 15

Received 15ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Group Type EXPERIMENTAL

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%

Erector 20

Received 20ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Group Type EXPERIMENTAL

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine 0.25% Injectable Solution

Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18-65 years.
2. Both genders.
3. American Society of Anesthesiologists' (ASA) physical status I or II.
4. Undergoing single level lumbar spine fixation.

Exclusion Criteria

1. Patient refusal.
2. Pregnant females.
3. Renal, lung, heart, or liver disorders.
4. Communication difficulties which might prevent a reliable postoperative assessment.
5. Contraindication to regional anesthesia (bleeding disorder, use of any anticoagulants, local infection, known allergy to local anesthetics).
6. BMI more than 30 kg/m2.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No